Jazz Pharmaceuticals (Germany) Investor Sentiment

J7Z Stock  EUR 116.85  1.15  0.97%   
Roughly 61% of Jazz Pharmaceuticals' investor base is looking to short. The analysis of current outlook of investing in Jazz Pharmaceuticals plc suggests that many traders are alarmed regarding Jazz Pharmaceuticals' prospects. The current market sentiment, together with Jazz Pharmaceuticals' historical and current headlines, can help investors time the market. In addition, many technical investors use Jazz Pharmaceuticals plc stock news signals to limit their universe of possible portfolio assets.
Jazz Pharmaceuticals stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Jazz daily returns and investor perception about the current price of Jazz Pharmaceuticals plc as well as its diversification or hedging effects on your existing portfolios.
  
few days ago at news.google.com         
Bruce Cozadd to Retire as Chief Executive Officer of Jazz Pharmaceuticals plc Upon Appointment of Su...
Google News at Macroaxis
over a week ago at news.google.com         
State Street Corp Sells 71,036 Shares of Jazz Pharmaceuticals plc - MarketBeat
Google News at Macroaxis
over a week ago at news.google.com         
Y Intercept Hong Kong Ltd Cuts Holdings in Jazz Pharmaceuticals plc - MarketBeat
Google News at Macroaxis
over a week ago at news.google.com         
Avadel Pharmaceuticals director Linda Palczuk buys 30,567 in shares - Investing.com
Google News at Macroaxis
over two weeks ago at news.google.com         
Quantinno Capital Management LP Acquires 42,924 Shares of Jazz Pharmaceuticals plc - MarketBeat
Google News at Macroaxis
over two weeks ago at news.google.com         
Insider Sell Bruce Cozadd Sells 2,000 Shares of Jazz Pharmaceuticals PLC - GuruFocus.com
Google News at Macroaxis
over two weeks ago at news.google.com         
Jazz Pharmaceuticals CEO Bruce Cozadd sells 242,340 in shares - Investing.com
Google News at Macroaxis
over two weeks ago at news.google.com         
Jazz Pharmaceuticals plc Sees Significant Increase in Short Interest - MarketBeat
Google News at Macroaxis
over two weeks ago at news.google.com         
5 Attractive Biotechnology Stocks For Healthy Long-Term Returns - Investing.com
Google News at Macroaxis
over two weeks ago at news.google.com         
Intech Investment Management LLC Reduces Stock Position in Jazz Pharmaceuticals plc - MarketBeat
Google News at Macroaxis
over three weeks ago at news.google.com         
Why Jazz Pharmaceuticals Is One of the Most Undervalued Pot Stocks to Buy - Yahoo Finance
Google News at Macroaxis
over a month ago at news.google.com         
Thompson Siegel Walmsley LLC Increases Stock Position in Jazz Pharmaceuticals plc - MarketBeat
Google News at Macroaxis
over a month ago at news.google.com         
JAZZ COGS-to-Revenue 0.11 - GuruFocus.com
Google News at Macroaxis
over a month ago at news.google.com         
Jazz Pharmaceuticals shares target raised on patient base growth - Investing.com
Google News at Macroaxis
over a month ago at news.google.com         
Jazz Pharmaceuticals Performance Is Even Better Than Its Earnings Suggest - Yahoo Finance
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Jazz Pharmaceuticals that are available to investors today. That information is available publicly through Jazz media outlets and privately through word of mouth or via Jazz internal channels. However, regardless of the origin, that massive amount of Jazz data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Jazz Pharmaceuticals news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Jazz Pharmaceuticals relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Jazz Pharmaceuticals' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Jazz Pharmaceuticals alpha.

Jazz Pharmaceuticals Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for Jazz Stock analysis

When running Jazz Pharmaceuticals' price analysis, check to measure Jazz Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jazz Pharmaceuticals is operating at the current time. Most of Jazz Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Jazz Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jazz Pharmaceuticals' price. Additionally, you may evaluate how the addition of Jazz Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
CEOs Directory
Screen CEOs from public companies around the world
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios